|
1.
|
Rousset D, Agnès F, Lachaume P, André C
and Galibert F: Molecular evolution of the genes encoding receptor
tyrosine kinase with immunoglobulin like domains. J Mol Evol.
41:421–429. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Anderson DM, Lyman SD, Baird A, Wignall
JM, Eisenman J, Rauch C, March CJ, Boswell HS, Gimpel SD and Cosman
D: Molecular cloning of mast cell growth factor, a hematopoietin
that is active in both membrane bound and soluble forms. Cell.
63:235–243. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Miyazawa K, Williams DA, Gotoh A,
Nishimaki J, Broxmeyer HE and Toyama K: Membrane-bound steel factor
induces more persistent tyrosine kinase activation and longer life
span of c-kit gene-encoded protein than its soluble form. Blood.
85:641–649. 1995.PubMed/NCBI
|
|
4.
|
Cohen PS, Chan JP, Lipkunskaya M, Biedler
JL and Seeger RC: Expression of stem cell factor and c-kit in human
neuroblastoma. The children’s cancer group. Blood. 84:3465–3472.
1994.
|
|
5.
|
Hassan S, Kinoshita Y, Kawanami C, Kishi
K, Matsushima Y, Ohashi A, Funasaka Y, Okada A, Maekawa T, He-Yao W
and Chiba T: Expression of proto-oncogene c-kit and its ligand stem
cell factor (SCF) in gastric carcinoma cell lines. Dig Dis Sci.
43:8–14. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Hines SJ, Organ C, Kornstein MJ and
Krystal GW: Coexpression of the c-kit and stem cell factor genes in
breast carcinomas. Cell Growth Differ. 6:769–779. 1995.PubMed/NCBI
|
|
7.
|
Inoue M, Kyo S, Fujita M, Enomoto T and
Kondoh G: Coexpression of the c-kit receptor and the stem cell
factor in gynecological tumors. Cancer Res. 54:3049–3053.
1994.PubMed/NCBI
|
|
8.
|
Krystal GW, Hines SJ and Organ CP: Organ.
Autocrine growth of small cell lung cancer mediated by coexpression
of c-kit and stem cell factor. Cancer Res. 56:370–376.
1996.PubMed/NCBI
|
|
9.
|
Pietsch T, Kyas U, Steffens U, Yakisan E,
Hadam MR, Ludwig WD, Zsebo K and Welte K: Effects of human stem
cell factor (c-kit ligand) on proliferation of myeloid leukemia
cells: Heterogeneity in response and synergy with other
hematopoietic growth factors. Blood. 80:1199–206. 1992.PubMed/NCBI
|
|
10.
|
Toyota M, Hinoda Y, Takaoka A, Makiguchi
Y, Takahashi T, Itoh F, Imai K and Yachi A: Expression of c-kit and
kit ligand in human colon carcinoma cells. Tumour Biol. 14:295–302.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Kindblom LG, Remotti HE, Aldenborg F and
Meis-Kindblom JM: Gastrointestinal pacemaker cell tumor (GIPACT):
gastrointestinal stromal tumors show phenotypic characteristics of
the interstitial cells of Cajal. Am J Pathol. 152:1259–1269.
1998.
|
|
12.
|
Heinrich MC, Corless CL, Demetri GD,
Blanke CD, von Mehren M, Joensuu H, McGreevey LS, Chen CJ, Van den
Abbeele AD, Druker BJ, Kiese B, et al: Kinase mutations and
imatinib response in patients with metastatic gastrointestinal
stromal tumor. J Clin Oncol. 21:4342–4349. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Hirota S, Isozaki K, Moriyama Y, Hashimoto
K, Nishida T, Ishiguro S, Kawano K, Hanada M, Kurata A, Takeda M,
Muhammad Tunio G, et al: Gain-of-function mutations of c-kit in
human gastrointestinal stromal tumors. Science. 279:577–580. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Rubin BP, Singer S, Tsao C, Duensing A,
Lux ML, Ruiz R, Hibbard MK, Chen CJ, Xiao S, Tuveson DA, Demetri
GD, et al: KIT activation is a ubiquitous feature of
gastrointestinal stromal tumors. Cancer Res. 61:8118–8121.
2001.PubMed/NCBI
|
|
15.
|
Wardelmann E, Losen I, Hans V, Neidt I,
Speidel N, Bierhoff E, Heinicke T, Pietsch T, Büttner R and
Merkelbach-Bruse S: Deletion of Trp-557 and Lys-558 in the
juxtamembrane domain of the c-kit protooncogene is associated with
metastatic behavior of gastrointestinal stromal tumors. Int J
Cancer. 106:887–895. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Emile JF, Théou N, Tabone S, Cortez A,
Terrier P, Chaumette MT, Julié C, Bertheau P, Lavergne-Slove A,
Donadieu J, Barrier A, et al: A clinicopathologic, phenotypic, and
genotypic characteristics of gastrointestinal mesenchymal tumors.
Clin Gastroenterol Hepatol. 2:597–605. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Debiec-Rychter M, Sciot R, Le Cesne A,
Schlemmer M, Hohenberger P, van Oosterom AT, Blay JY, Leyvraz S,
Stul M, Casali PG, Zalcberg J, et al EORTC Soft Tissue and Bone
Sarcoma Group; Italian Sarcoma Group; Australasian GastroIntestinal
Trials Group: KIT mutations and dose selection for imatinib in
patients with advanced gastrointestinal stromal tumours. Eur J
Cancer. 42:1093–1103. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Heinrich MC, Corless CL, Blanke CD,
Demetri GD, Joensuu H, Roberts PJ, Eisenberg BL, von Mehren M,
Fletcher CD, Sandau K, McDougall K, et al: Molecular correlates of
imatinib resistance in gastrointestinal stromal tumors. J Clin
Oncol. 24:4764–4774. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Demetri GD, von Mehren M, Blanke CD, Van
den Abbeele AD, Eisenberg B, Roberts PJ, Heinrich MC, Tuveson DA,
Singer S, Janicek M, Fletcher JA, et al: Efficacy and safety of
imatinib mesylate in advanced gastrointestinal stromal tumors. N
Engl J Med. 347:472–480. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Bono P, Krause A, von Mehren M, Heinrich
MC, Blanke CD, Dimitrijevic S, Demetri GD and Joensuu H: Serum KIT
and KIT ligand levels in patients with gastrointestinal stromal
tumors treated with Imatinib. Blood. 103:2929–2935. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Hirano K, Shishido-Hara Y, Kitazawa A,
Kojima K, Sumiishi A, Umino M, Kikuchi F, Sakamoto A, Fujioka Y and
Kamma H: Expression of stem cell factor (SCF), a KIT ligand, in
gastrointestinal stromal tumors (GISTs): a potential marker for
tumor proliferation. Pathol Res Pract. 204:799–807. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Théou-Anton N, Tabone S, Brouty-Boyé D,
Saffroy R, Ronnstrand L, Lemoine A and Emile JF: Co expression of
SCF and KIT in gastrointestinal stromal tumours (GISTs) suggests an
autocrine/paracrine mechanism. Br J Cancer. 94:1180–1185.
2006.PubMed/NCBI
|
|
23.
|
Duensing A, Medeiros F, McConarty B,
Joseph NE, Panigrahy D, Singer S, Fletcher CD, Demetri GD and
Fletcher JA: Mechanisms of oncogenic KIT signal transduction in
primary gastrointestinal stromal tumors (GISTs). Oncogene.
23:3999–4006. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Lux ML, Rubin BP, Biase TL, Chen CJ,
Maclure T, Demetri G, Xiao S, Singer S, Fletcher CD and Fletcher
JA: KIT extracellular and kinase domain mutations in
gastrointestinal stromal tumors. Am J Pathol. 156:791–795. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Théou N, Tabone S, Saffroy R, Le Cesne A,
Julié C, Cortez A, Lavergne-Slove A, Debuire B, Lemoine A and Emile
JF: High expression of both mutant and wild-type alleles of c-KIT
in gastrointestinal stromal tumors. Biochim Biophys Acta.
1688:250–256. 2004.PubMed/NCBI
|
|
26.
|
Pedersen M, Rönnstrand L and Sun J: The
c-Kit/D816V mutation eliminates the differences in signal
transduction and biological responses between two isoforms of
c-Kit. Cell Signal. 21:413–418. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Tabone-Eglinger S, Subra F, El Sayadi H,
Alberti L, Tabone E, Michot JP, Théou-Anton N, Lemoine A, Blay JY
and Emile JF: KIT mutations induce intracellular retention and
activation of an immature form of the KIT protein in
gastrointestinal stromal tumors. Clin Cancer Res. 14:2285–2294.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Negri T, Bozzi F, Conca E, Brich S,
Gronchi A, Bertulli R, Fumagalli E, Pierotti MA, Tamborini E and
Pilotti S: Oncogenic and ligand-dependent activation of KIT/PDGFRA
in surgical samples of imatinib-treated gastrointestinal stromal
tumours (GISTs). J Pathol. 217:103–112. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Hofmann UB, Kauczok-Vetter CS, Houben R
and Becker JC: Overexpression of the KIT/SCF in uveal melanoma does
not translate into clinical efficacy of imatinib mesylate. Clin
Cancer Res. 15:324–329. 2009. View Article : Google Scholar : PubMed/NCBI
|
